CDEK
← All organizations

Ambrx

For profit

Also known as: Ambrx, Inc. | Ambryx Biotechnology

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Nov 1, 2006

Last known activity

Oct 15, 2024

Acquired by Johnson and Johnson on Jan 8, 2024

Timeline

2000s

  1. Jan 1, 2003

    Ambrx— Founded

2020s

  1. Jan 8, 2024

    Johnson and Johnson— Acquired By

Drugs by trial phase (4 distinct, 8 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

Details

Founded
La Jolla, CA, US Jan 1, 2003
Last known activity
Oct 15, 2024